Impact of Vitamin D on Diabetic Kidney Disease in African Americans

• Status: Unknown status
• Trial end date: 0000-00-00
• Target enrollment: 102
• Participant gender: Both

Summary

This purpose of this project is to evaluate the effectiveness of vitamin D supplementation over 12 months in vitamin D deficient African American adults with type 2 diabetes.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical University of South Carolina
• Treatments: Calcium Carbonate; Calcium, Dietary; Cholecalciferol; Ergocalciferols; Vitamin D; Vitamins
• Last Updated: 2011-06-13

Criteria

Inclusion Criteria:

• African American race

• Diagnosis of Type 2 Diabetes

• Stage 1 or 2 Kidney Disease with detectable microalbuminuria >4.0 (mg/g) 25(OH)D level <20 ng/ml

Exclusion Criteria:

• Type 1 diabetes

--> Stage 3 Kidney Disease, or history of dialysis, kidney transplantation or nephrolithiasis

• Unable to provide informed consent or contact information

• Pre-existing calcium or parathyroid condition, including serum calcium >10.2 mg/dL

• Sarcoidosis, active tuberculosis, or malignancy

• Known hypersensitivity to vitamin D or any of its analogues and derivatives

• Current pregnancy or planning to become pregnant in next 15 months